4.5 Article

Gamendazole, an orally active indazole carboxylic acid male contraceptive agent, targets HSP90AB1 (HSP90BETA) and EEF1A1 (eEF1A), and stimulates Il1a transcription in rat sertoli cells

期刊

BIOLOGY OF REPRODUCTION
卷 78, 期 6, 页码 1139-1152

出版社

OXFORD UNIV PRESS INC
DOI: 10.1095/biolreprod.107.062679

关键词

fertilization; male contraception; Sertoli cells; spermatogenesis; testis

资金

  1. NICHD NIH HHS [U54 HD-055763, N01-HD-1-3313, U54 HD055763, U54 HD33994, N01-HD-6-3259] Funding Source: Medline
  2. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD033994, U54HD055763, N01HD063259] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Gamendazole was recently identified as an orally active antispermatogenic compound with antifertility effects. The cellular mechanism(s) through which these effects occur and the molecular target(s) of gamendazole action are currently unknown. Gamendazole was recently designed as a potent orally active anti spermatogenic male contraceptive agent. Here, we report the identification of binding targets and propose a testable mechanism of action for this antispermatogenic agent. Both HSP90AB1 (previously known as HSP90beta [heat shock 90-kDa protein 1, beta]) and EEF1A1 (previously known as eEF1A [eukaryotic translation elongation factor 1 alpha 1]) were identified as binding targets by biotinylated gamendazole (BT-GMZ) affinity purification from testis, Sertoli cells, and ID8 ovarian cancer cells; identification was confirmed by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and Western blot analysis. BT-GMZ bound to purified yeast HSP82 (homologue to mammalian HSP90AB1) and EEF1A1, but not to TER or HBS1, and was competed by unlabeled gamendazole. However, gamendazole did not inhibit nucleotide binding by EEF1A1. Gamendazole binding to purified Saccharomyces cerevisiae HSP82 inhibited luciferase refolding and was not competed by the HSP90 drugs geldanamycin or novobiocin analogue, KU-1. Gamendazole elicited degradation of the HSP90-dependent client proteins AKT1 and ERB132 and had an antiproliferative effect in MCF-7 cells without inducing HSP90. These data suggest that gamendazole may represent a new class of selective HSP90AB1) and EEF1A1 inhibitors. Testis gene microarray analysis from gamendazole-treated rats showed a marked, rapid increase in three interleukin 1 genes and Nfkbia (NF-kappaB inhibitor alpha) 4 h after oral administration. A spike in Il1a transcription was confirmed by RT-PCR in primary Sertoli cells 60 min after exposure to 100 nM gamendazole, demonstrating that Sertoli cells are a target. AKT1, NFKB, and interleukin 1 are known regulators of the Sertoli cell-spermatid junctional complexes. A current model for gamendazole action posits that this pathway links interaction with HSP90AB1 and EEF1A1 to the loss of spermatids and resulting infertility.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Dihydropyridine Lactam Analogs Targeting BET Bromodomains

Jiewei Jiang, Logan H. Sigua, Alice Chan, Prakriti Kalra, William C. K. Pomerantz, Ernst Schonbrunn, Jun Qi, Gunda Georg

Summary: The study focused on structural modifications of a previously reported compound to improve affinity for BRDT by altering linker length and type. The analogs were found to be highly selective for BET bromodomains, with a preference for the BD1 and BD2 bromodomains of BRD4 over BRDT.

CHEMMEDCHEM (2022)

Article Pharmacology & Pharmacy

Steroidal Antagonists of Progesterone- and Prostaglandin E1-Induced Activation of the Cation Channel of Sperm

Erick J. Carlson, Gunda Georg, Jon E. Hawkinson

Summary: In this study, it was found that medroxyprogesterone acetate, levonorgestrel, and aldosterone selectively antagonize the calcium influx induced by progesterone and prostaglandin E1 through the CatSper cation channel in human sperm. Unlike T-type calcium channel blockers, these steroid antagonists preferentially reduce hyperactivated sperm motility, which is essential for fertilization. The discovery of these competitive antagonists provides a starting point for the development of male contraceptive agents acting through this unique mechanism.

MOLECULAR PHARMACOLOGY (2022)

Article Chemistry, Medicinal

Discovery and Characterization of Multiple Classes of Human CatSper Blockers

Erick J. Carlson, Rawle Francis, Yutong Liu, Ping Li, Maximilian Lyon, Celia M. Santi, Derek J. Hook, Jon E. Hawkinson, Gunda Georg

Summary: This study identified novel inhibitors targeting the cation channel of sperm and investigated one promising compound in depth. These inhibitors showed high selectivity for CatSper channel and inhibited hyperactivated sperm motility.

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

1,4-Dihydropyridinebutyrolactone-derived ring-opened ester and amide analogs targeting BET bromodomains

Jiewei Jiang, Pei-Liang Zhao, Logan H. Sigua, Alice Chan, Ernst Schonbrunn, Jun Qi, Gunda Georg

Summary: Nine lactone ring-opened ester and seven amide analogs were synthesized based on a previously reported virtual screening hit. However, there was no significant improvement in the affinity and selectivity for BET bromodomains. X-ray analysis showed that the ester side chain was located near the ZA loop and exposed to solvent.

ARCHIV DER PHARMAZIE (2022)

Article Chemistry, Medicinal

Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity

Xianghong Guan, Narsihmulu Cheryala, Rezaul Md. Karim, Alice Chan, Norbert Berndt, Jun Qi, Gunda I. Georg, Ernst Schonbrunn

Summary: Bromodomain and extraterminal domain (BET) proteins, including BRD4 and BRDT, play crucial roles in gene transcription and chromatin remodeling. Novel bivalent inhibitors show increased activity and selectivity for BRDT, due to differential plasticity of BET bromodomains upon inhibitor-induced dimerization. X-ray crystallographic and solution studies reveal unique structural states of BET proteins upon interaction with bivalent inhibitors.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Pharmacology & Pharmacy

Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier

Raymond K. Hau, Joseph S. Tash, Gunda I. Georg, Stephen H. Wright, Nathan J. Cherrington

Summary: This study characterizes the carrier-mediated processes that allow H2-GMZ and other drugs to enter Sertoli cells, and explores the impact of the blood-testis barrier on the pharmacokinetics and pharmacodynamics of drugs.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2022)

Correction Chemistry, Medicinal

Discovery and Characterization of Multiple Classes of Human CatSper Blockers (vol 17, e202000499, 2022)

Erick J. Carlson, Rawle Francis, Yutong Liu, Ping Li, Maximilian Lyon, Celia M. Santi, Derek J. Hook, Jon E. Hawkinson, Gunda I. Georg

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

Investigation of selective retinoic acid receptor alpha antagonist ER-50891 and related analogs for male contraception

Jillian L. Kyzer, Md Abdullah Al Noman, Rebecca A. D. Cuellar, Sanny S. W. Chung, Soma Maitra, Tahmina Naqvi, Jon E. Hawkinson, Debra J. Wolgemuth, Gunda I. Georg

Summary: Retinoic acid receptor alpha (RAR alpha) antagonist ER-50891 and its 15 analogs were studied for their potency and selectivity at RAR alpha, RAR beta, and RAR gamma in vitro. Minor modifications to the parent molecule, such as introducing a C4 tolyl group instead of the C4 phenyl group on the quinoline moiety, slightly increased the selectivity for RAR alpha, while larger substituents significantly decreased potency. Replacement of the pyrrole moiety of ER-50891 with triazole, amides, or a double bond resulted in inactive compounds. ER-50891 was stable in male mouse liver microsomes and its effects on spermatogenesis were observed in male mice, showing characteristic albeit modest and transient effects.

ARCHIV DER PHARMAZIE (2023)

Editorial Material Chemistry, Medicinal

Enhancing the Visibility of Women in the ACS Division of Medicinal Chemistry (ACS MEDI)

Jane Aldrich, Shelley Allen, Erika Araujo, Joanne Bronson, Amanda Bryant-Friedrich, Shana K. Cyr, Erin F. DiMauro, Carolyn Dzierba, Amanda L. Garner, Gunda I. Georg, Nicole C. Goodwin, Krupanandan Haranahalli, Rong Huang, Katerina Leftheris, Tricia L. May-Dracka, Margaret E. Olson, Maria-Jesus Blanco

Summary: On March 8, 2023, the International Women's Day, we want to celebrate and highlight the contributions of many women volunteers in the American Chemical Society Division of Medicinal Chemistry (ACS MEDI).

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Editorial Material Chemistry, Medicinal

Excellence in Medicinal Chemistry: Celebrating ACS Medicinal Chemistry Division (MEDI) Awards. A Call for Nominations

Maria-Jesus Blanco, Amanda Bryant-Friedrich, Gunda Georg, Amjad Ali, Paul L. L. Ornstein, Lori Ferrins, Paul C. C. Trippier

Summary: The American Chemical Society Division of Medicinal Chemistry (MEDI) awards achievements in medicinal chemistry through a variety of awards, fellowships, and honors. In celebration of the Gertrude Elion Medical Chemistry Award, the ACS MEDI Division wishes to inform the community about the numerous awards, fellowships, and travel grants available to members.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Editorial Material Chemistry, Medicinal

Enhancing the Visibility of Women in the ACS Division of Medicinal Chemistry (ACS MEDI)

Jane Aldrich, Shelley Allen, Erika Araujo, Joanne Bronson, Amanda Bryant-Friedrich, Shana K. Cyr, Erin F. DiMauro, Carolyn Dzierba, Amanda L. Garner, Gunda I. Georg, Nicole C. Goodwin, Krupanandan Haranahalli, Rong Huang, Katerina Leftheris, Tricia L. May-Dracka, Margaret E. Olson, Maria-Jesus Blanco

Summary: On the occasion of the 2023 International Women's Day on March 8, 2023, we want to celebrate and highlight the contributions of many women volunteers in the American Chemical Society Division of Medicinal Chemistry (ACS MEDI).

ACS MEDICINAL CHEMISTRY LETTERS (2023)

Editorial Material Chemistry, Medicinal

Excellence in Medicinal Chemistry: Celebrating ACS Medicinal Chemistry Division (MEDI) Awards. A Call for Nominations

Maria-Jesus Blanco, Amanda Bryant-Friedrich, Gunda Georg, Amjad Ali, Paul L. Ornstein, Lori Ferrins, Paul C. Trippier

Summary: The American Chemical Society Division of Medicinal Chemistry (MEDI) bestows a range of awards, fellowships, and honors to acknowledge outstanding contributions in medicinal chemistry. In celebration of the creation of the Gertrude Elion Medical Chemistry Award, the ACS MEDI Division aims to inform the community about the various available awards, fellowships, and travel grants for members.

ACS MEDICINAL CHEMISTRY LETTERS (2023)

Biographical-Item Chemistry, Medicinal

Patrick M. Woster Memorial Commentary

David P. Rotella, Gunda Georg

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Strategies for developing retinoic acid receptor alpha-selective antagonists as novel agents for male contraception

Md Abdullah Al Noman, Rebecca A. D. Cuellar, Jillian L. Kyzer, Sanny S. W. Chung, Narsihmulu Cheryala, Trinh A. D. Holth, Soma Maitra, Tahmina Naqvi, Henry L. Wong, Ernst Schonbrunn, Jon E. Hawkinson, Debra J. Wolgemuth, Gunda I. Georg

Summary: A series of retinoic acid analogs based on dihydronaphthalene and chromene scaffolds were synthesized and evaluated in vitro. Compound 21, a chromene amide analog, was identified as the most potent retinoic acid receptor alpha antagonist with favorable physicochemical properties and pharmacokinetic profile. In a mouse model, compound 21 showed modest effects on spermatogenesis at low doses, but did not impact fertility. Further investigation on its effects on male fertility may not be warranted.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Physiology

The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease

Shirin V. Sundar, Julie Xia Zhou, Brenda S. Magenheimer, Gail A. Reif, Darren P. Wallace, Gunda I. Georg, Sudhakar R. Jakkaraj, Joseph S. Tash, Alan S. L. Yu, Xiaogang Li, James P. Calvet

Summary: Autosomal dominant polycystic kidney disease (ADPKD) is a debilitating renal neoplastic disorder characterized by the formation of large fluid-filled cysts. A study found that the lonidamine derivative H2-GMZ inhibits Cl- secretion, cell proliferation, and cyst growth, suggesting its potential therapeutic value for ADPKD treatment.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2022)

暂无数据